Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Peripheral Arterial Disease: Features

Voyager Analysis
Videos
ACC.20/WCC – Hiatt: VOYAGER PAD Subgroup Analysis
03/29/2020
William R. Hiatt, MD, Professor of Medicine/Cardiology at the University of Colorado School of Medicine, and Chief Science Officer at CPC Clinical Research, Denver, Colorado.
William R. Hiatt, MD, Professor of Medicine/Cardiology at the University of Colorado School of Medicine, and Chief Science Officer at CPC Clinical Research, Denver, Colorado.
William R. Hiatt, MD, Professor...
03/29/2020
Vascular Disease Management
ACC.20/WCC – Bonaca: VOYAGER PAD Trial Summary
Videos
ACC.20/WCC – Bonaca: VOYAGER PAD Trial Summary
03/28/2020
Marc P. Bonaca, MD, Associate Professor and Director of Vascular Research at the University of Colorado School of Medicine and CPC Clinical Research, Aurora, Colorado, discusses his presentation at ACC.20/WCC of the VOYAGER PAD trial.
Marc P. Bonaca, MD, Associate Professor and Director of Vascular Research at the University of Colorado School of Medicine and CPC Clinical Research, Aurora, Colorado, discusses his presentation at ACC.20/WCC of the VOYAGER PAD trial.
Marc P. Bonaca, MD, Associate...
03/28/2020
Vascular Disease Management
The COMPARE Trial: High- vs Low-Dose Drug-Coated Balloons
Videos
The COMPARE Trial: High- vs Low-Dose Drug-Coated Balloons
03/14/2020
Prof. Dierk Scheinert
Prof. Dierk Scheinert
Prof. Dierk Scheinert
03/14/2020
Vascular Disease Management
A Discussion of Tibial-Pedal Intervention
Videos
A Discussion of Tibial-Pedal Intervention
03/14/2020
John Rundback, MD
John Rundback, MD
John Rundback, MD
03/14/2020
Vascular Disease Management
5-Year Results From the ABSORB BTK Study: Bioresorbable Scaffolds for the Treatment of Tibial Artery Stenosis
Videos
5-Year Results From the ABSORB BTK Study: Bioresorbable Scaffolds for the Treatment of Tibial Artery Stenosis
03/14/2020
Ramon Varcoe, MBBS, MS, PhD
Ramon Varcoe, MBBS, MS, PhD
Ramon Varcoe, MBBS, MS, PhD
03/14/2020
Vascular Disease Management
High Prevalence of Asymptomatic Ischemia-Producing Coronary Stenosis in Patients With Critical Limb Ischemia: Anatomic and Functional Assessment With Coronary CT-Derived Fractional Flow Reserve (FFRCT)
Original Research
High Prevalence of Asymptomatic Ischemia-Producing Coronary Stenosis in Patients With Critical Limb Ischemia: Anatomic and Functional Assessment With Coronary CT-Derived Fractional Flow Reserve (FFRCT)
03/12/2020
CLI patients with no cardiac history undergoing limb salvage surgery have a high prevalence of asymptomatic ischemia-producing coronary stenosis, which may put them at increased risk.
CLI patients with no cardiac history undergoing limb salvage surgery have a high prevalence of asymptomatic ischemia-producing coronary stenosis, which may put them at increased risk.
CLI patients with no cardiac...
03/12/2020
Vascular Disease Management
Crossing Complex Tibial Lesions: How to Start and When to Escalate Wire Choices
Videos
Crossing Complex Tibial Lesions: How to Start and When to Escalate Wire Choices
03/03/2020
Paul Michael, MD, describes the need for both preventing disease and educating specialized personnel.
Paul Michael, MD, describes the need for both preventing disease and educating specialized personnel.
Paul Michael, MD, describes the...
03/03/2020
Vascular Disease Management
Gray: Paclitaxel and the Mortality Signal
Videos
Gray: Paclitaxel and the Mortality Signal
02/28/2020
William Gray, MD
William Gray, MD
William Gray, MD
02/28/2020
Vascular Disease Management
Parikh: Options for Femoral Popliteal Intervention
Videos
Parikh: Options for Femoral Popliteal Intervention
02/27/2020
Sahil Parikh, MD
Sahil Parikh, MD
Sahil Parikh, MD
02/27/2020
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement